Search results for "Pepsinogens"

showing 4 items of 4 documents

Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy

2019

Background Atrophic gastritis is considered precursor condition for gastric cancer. There is so far limited evidence on the performance of pepsinogens for atrophy detection in Central Asia. The aim of our study was to detect the prevalence of atrophic gastritis in the asymptomatic adult population in Kazakhstan as well as address the accuracy of pepsinogen testing in atrophy detection. Methods Healthy individuals aged 40-64 were included. Upper endoscopy and pepsinogens (PG) evaluation were performed. PG were analysed in plasma by latex agglutination. Cut off values were used to define decreased PG values (PGR ≤ 3 and PG I ≤ 70 ng/mL); severely decreased PG values (PGR ≤ 2 and PG I ≤ 30 ng/…

AdultGastritis AtrophicMale0301 basic medicinemedicine.medical_specialtyAtrophic gastritisPopulationgastricAsymptomaticGastroenterology03 medical and health sciences0302 clinical medicineAtrophyatrophyPepsinPepsinogen AInternal medicinePrevalenceHumansMedicineeducationeducation.field_of_studyPepsinogensbiologyatrophicbusiness.industrygastric cancerscreeninggastritisEndoscopyGeneral MedicineGold standard (test)Middle AgedPrognosismedicine.diseaseKazakhstanLatex fixation test030104 developmental biologyROC CurveGastric Mucosa030220 oncology & carcinogenesisbiology.proteinFemaleGastritismedicine.symptombusinessResearch ArticleFollow-Up StudiesAsian Pacific Journal of Cancer Prevention
researchProduct

Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.

2017

Background Circulating levels of pepsinogens have been used in high gastric cancer-risk Asian and European populations to triage endoscopic evaluation for more severe pathology. There are different analytic methods with uncertain correlations. We therefore compared diagnostic performance of three commonly used pepsinogen assays to detect histologically confirmed gastric atrophy. Methods We tested plasma samples from adult patients with (n=50) and without (n=755) moderate or severe gastric corpus atrophy, as determined histologically by consensus of three expert pathologists. A single laboratory measured pepsinogens I (PgI) and II (PgII) using commercially available assays: two ELISA assays …

AdultMalePathologymedicine.medical_specialtyAdolescentStomach DiseasesEnzyme-Linked Immunosorbent AssayGastroenterologyArticle03 medical and health sciencesYoung Adult0302 clinical medicineAtrophyPepsinInternal medicineMedicineHumansAgedAged 80 and overAdult patientsPlasma samplesReceiver operating characteristicbiologyPepsinogensbusiness.industryDiagnostic Tests RoutineHistocytochemistryGastric AtrophyStomachGastroenterologyGeneral MedicineMiddle Agedmedicine.diseasedigestive system diseasesInfectious Diseasesmedicine.anatomical_structureROC CurveGastric Mucosa030220 oncology & carcinogenesisbiology.protein030211 gastroenterology & hepatologyTest performanceFemaleAtrophybusinessLatex Fixation TestsHelicobacter
researchProduct

Antivielas pret parietālajām šūnām un iekšējo faktoru kuņģa vēža pacientiem

2022

Ievads. Saistība starp H. pylori infekciju un kuņģa adenokarcinomas attīstību ir plaši pētīta, bet autoimūnā gastrīta nozīmei nav pievērsta tik liela uzmanība. Mērķis. Noteikt kuņģa adenokarcinomas pacientu īpatsvaru ar pozitīvām pret partikulāro šūnu (APCA) un anti intrīna faktora (IF) antivielām, izpētīt saistību starp kuņģa atrofijas marķieriem, H. pylori un auto antivielu pozitīvismu, kā arī novērtēt vairākas adenokarcinomas pazīmes saistībā ar autoimūno gastrītu. Materiāli un metodes. Pacientiem ar morfoloģiski apstiprinātu kuņģa adenokarcinomu tika izmērīts APCA un anti-IF antivielu līmenis un novērtēta to saistība ar PGI/PGII attiecību, kā arī H. pylori IgG līmeni. APCA un anti-IF an…

Anti-parietal cell antibodyAutoimmune gastritisPepsinogensAnti-intrinsic factor antibodyGastric cancerMedicīna
researchProduct

Zinc acexamate inhibits gastric acid and pepsinogen secretion in the rat.

1990

Abstract Pretreatment with zinc acexamate (25–100 mg kg−1 i.p.) inhibited acid and pepsinogen secretion in the pylorus-ligated rat. Zinc acexamate (5–50 mg kg−1 p.o.) also inhibited the increases in acid secretion induced by carbachol (10 μg kg−1) and 2-deoxy-D-glucose (200 mg kg−1) in the perfused stomach of the anaesthetized rat. A delayed antisecretory effect was observed with this drug on histamine induced responses. High concentrations of zinc acexamate (10−5-10−2 M) did not modify the in-vitro activity of pepsin. Administration of zinc acexamate resulted in an increase in the presence of pepsinogen at the mucosal level. A morphological examination of the gastric mucosa confirmed an ac…

medicine.medical_specialtyCarbacholPharmaceutical Sciencechemistry.chemical_elementZincGastric Acidchemistry.chemical_compoundPepsinInternal medicinemedicineGastric mucosaAnimalsAnesthesiaPylorusPharmacologyAminocaproatesbiologyPepsinogensChemistryStomachRatsGastric chief cellPerfusionmedicine.anatomical_structureEndocrinologyGastric MucosaAminocaproic Acidbiology.proteinGastric acidHistaminemedicine.drugThe Journal of pharmacy and pharmacology
researchProduct